|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.86 USD | -1.97% |
|
-1.42% | -4.06% |
| Market Cap | 3.55B 3.1B 2.89B 2.66B 4.99B 340B 5.11B 34.29B 13.4B 168B 13.35B 13.06B 581B | P/E 2026 * |
206x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.29B 2.87B 2.68B 2.46B 4.62B 315B 4.73B 31.73B 12.4B 156B 12.35B 12.08B 538B | EV / Sales 2026 * |
6.58x | EV / Sales 2027 * | 4.6x |
| Free-Float |
98.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcutis Biotherapeutics, Inc.
| 1 day | -1.97% | ||
| 1 week | -1.42% | ||
| Current month | +6.25% | ||
| 1 month | +3.19% | ||
| 3 months | +19.62% | ||
| 6 months | +9.47% | ||
| Current year | -4.06% |
| 1 week | 26.78 |  | 28.6 |
| 1 month | 25.25 | | 29.84 |
| Current year | 19.3 | | 30.75 |
| 1 year | 13.7 | | 31.77 |
| 3 years | 1.76 | | 31.77 |
| 5 years | 1.76 | | 31.77 |
| 10 years | 1.76 | | 40.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 58 | 01/04/2017 |
| Corporate Officer/Principal | 71 | 03/12/2025 | |
Latha Vairavan
DFI | Director of Finance/CFO | - | 15/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Heron
CHM | Chairman | 55 | 01/12/2019 |
Todd Watanabe
BRD | Director/Board Member | 58 | 01/01/2016 |
Howard Welgus
BRD | Director/Board Member | 74 | 01/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/07/26 | Other | Director | 187,500 | 0.1499% | ||
| 15/07/26 | Free | Director | 38,811 | 0.0310% | ||
| 15/07/26 | Fiscal year | Director | 12,922 | 0.0103% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.97% | -1.42% | +86.23% | +156.54% | 3.55B | |
| +0.03% | +3.00% | +24.49% | -6.79% | 70.73B | |
| +0.28% | +2.87% | +40.29% | +214.73% | 54.27B | |
| -4.52% | +47.90% | +47.90% | +47.90% | 49.28B | |
| +7.15% | +5.51% | -52.67% | -51.99% | 39.94B | |
| +1.76% | +2.99% | +61.84% | -21.11% | 30.36B | |
| -2.18% | +8.27% | +81.16% | +101.46% | 25.96B | |
| -2.36% | -8.67% | +60.69% | -54.08% | 22.14B | |
| -0.22% | -2.66% | -4.47% | +145.08% | 19.96B | |
| -2.35% | +1.32% | +80.71% | +142.71% | 16.77B | |
| Average | -0.00% | +1.86% | +42.62% | +67.44% | 33.3B | |
| Weighted average by Cap. | +0.21% | +2.50% | +33.26% | +54.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 500M 436M 407M 374M 702M 47.83B 719M 4.82B 1.89B 23.7B 1.88B 1.84B 81.71B | 647M 564M 527M 484M 909M 61.9B 930M 6.24B 2.44B 30.68B 2.43B 2.38B 106B |
| Net income | 18.54M 16.17M 15.09M 13.87M 26.04M 1.77B 26.65M 179M 69.9M 879M 69.62M 68.11M 3.03B | 136M 118M 110M 102M 191M 12.98B 195M 1.31B 512M 6.43B 510M 498M 22.18B |
| Net Debt | -265M -231M -215M -198M -371M -25.3B -380M -2.55B -997M -12.54B -993M -972M -43.23B | -580M -506M -472M -434M -814M -55.46B -833M -5.59B -2.19B -27.48B -2.18B -2.13B -94.74B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | $27.86 | -1.97% | 976,693 |
| 28/07/26 | $28.42 | +2.08% | 1,066,059 |
| 27/07/26 | $27.84 | +1.79% | 1,199,084 |
| 24/07/26 | $27.35 | +0.07% | 819,355 |
| 23/07/26 | $27.33 | -2.04% | 1,031,412 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARQT Stock
Select your edition
All financial news and data tailored to specific country editions
